Emotional Processing in Multiple Sclerosis / Clinically Isolated Syndrome: A Neuropsychological fMRI-study
Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Feb 24, 2016
Trial Information
Current as of May 14, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years and ≤ 85 years
- • Right handed
- • For patients: Diagnosis of CIS or diagnosis of MS since ≤5 years
- Exclusion Criteria:
- • Cognitive deficits as determined by a MMSE Score \< 25/30
- • Depression as determined by a HADS-D Score \> 7
- • Anxiety as determined by a HADS-A Score \> 7
- • Physical disabilities interfering with the study procedures or impacting outcome measures
- • Clinically significant diseases within 7 days prior to the study evaluations
- • Contraindications against cranial MRI without contrast
About Charite University, Berlin, Germany
Charité - Universitätsmedizin Berlin is a leading academic medical center in Germany, renowned for its commitment to excellence in research, education, and patient care. As one of Europe's largest university hospitals, Charité integrates cutting-edge clinical practices with innovative research initiatives, fostering interdisciplinary collaboration across various medical fields. The institution is dedicated to advancing healthcare through rigorous clinical trials, contributing to the development of new therapies and treatment protocols. With a strong emphasis on translational medicine, Charité aims to bridge the gap between scientific discovery and practical application, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Berlin, , Germany
Patients applied
Trial Officials
Friedemann Paul, MD
Principal Investigator
Charité Unversitätsmedizin Berlin, NeuroCure Clinical Research Center NCRC
Thomas D. Hälbig, MD
Principal Investigator
Charité Unversitätsmedizin Berlin, NeuroCure Clinical Research Center NCRC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials